Adherence to Antipsychotic Medications for Individuals With Schizophrenia (SAA)

Assesses adults 19–64 years of age who have schizophrenia and were dispensed and remained on an antipsychotic medication for at least 80% of their treatment period.

Why It Matters

Schizophrenia is a chronic and disabling psychiatric disorder that requires ongoing treatment and monitoring. Symptoms include hallucinations, illogical thinking, memory impairment and incoherent speech.1 Medication nonadherence is common and a major concern in the treatment of schizophrenia. Using antipsychotic medications as prescribed reduces the risk of relapse or hospitalization.2

Results

ADHERENCE TO ANTIPSYCHOTIC MEDICATIONS FOR INDIVIDUALS WITH SCHIZOPHRENIA
Commercial Medicaid Medicare
Year HMO PPO HMO HMO PPO
2016 59.2
2015 58.0
2014 60.1
2013 60.1

References

  1. American Psychiatric Association. Schizophrenia Fact Sheet. http://www.dsm5.org/Documents/Schizophrenia%20Fact%20Sheet.pdf.
  2. Busch, A.B., A.F. Lehman, H. Goldman, & R.G. Frank. 2009. “Changes over time and disparities in schizophrenia treatment quality.” Med Care 47(2), 199–207.

  • Save

    Save your favorite pages and receive notifications whenever they’re updated.

    You will be prompted to log in to your NCQA account.

  • Email

    Share this page with a friend or colleague by Email.

    We do not share your information with third parties.

  • Print

    Print this page.